Ullrich Graeven

12PUBLICATIONS
92CO-AUTHORS
Pacific Peoples nursingPredictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Dec 30, 2025
Patient Characteristics and Different Decision Paths for Establishing Palliative Care for Patients Admitted via the Emergency Department.

Christiane Munsch, Sebastian Bergrath, Jessika Stefanie Kreß

|Dec 19, 2025
Molecular and Clinical Characteristics of Patients with Non-Small Cell Lung Cancer Harboring KRAS G12V Mutations.

Felix John, Lea Ruge, Malte Verheyen

|Nov 18, 2025
Individual Patient Data Meta-Analysis of Consensus Molecular Subtypes as Biomarkers of First-Line Treatment in RAS Wild-Type Metastatic Colorectal Cancer.

Arndt Stahler, Dominik Paul Modest, Sebastian Stintzing

|Jul 30, 2025
Spatial Tumor Immune Microenvironment as a Prognostic and Predictive Biomarker in Anti-EGFR-Based Maintenance for RAS wt Metastatic CRC-The PanaMa (AIO KRK0212) Trial.

Alexej Ballhausen, Susanna Swoboda, David Horst

|Jun 03, 2024
CD8+ CD28- regulatory T cells after induction therapy predict progression-free survival in myeloma patients: results from the GMMG-HD6 multicenter phase III study.

Katharina Kriegsmann, Gigi Nu Hoang Quy Ton, Mohamed H S Awwad

|Apr 27, 2024
The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma-a randomized, open-label phase III trial of the European mantle cell lymphoma network.

Luca Fischer, Linmiao Jiang, Jan Dürig

Pageof 2

Frequent Collaborators

5 joint publications

Dominik Paul Modest

5 joint publications

Lothar Müller

5 joint publications

Arndt Stahler

5 joint publications

Volker Heinemann